It was a fools errand to go after Covid, when antibacterial efficacy and anti-inflammatory therapy had already both been proven (albeit minimally in terms of numbers). Value is still in B and K overall, but at this point we need Leo to step down. He’s clearly not capable of bringing us to the next level.
News 
Market Data 
Discover 
